- IO Biotechnology (Nasdaq:IOBT) entered into a loan facility of up to €57.5 million from the European Investment Bank.
- The debt facility includes three committed tranches totaling €37.5 million, which will become available if the company meets certain conditions, and one uncommitted tranche.
https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png
Source link